title: Colorectal cancer. Recent developments and continuing controversies.
abstract: In the last 2 years, much progress has been made in colorectal cancer research. Many of the findings, especially those involving adjuvant therapy, have important clinical applications. For example, fluorouracil (5-FU) (Adrucil) combined with levamisole hydrochloride (Ergamisol) is now recommended as adjuvant therapy for patients with Dukes' stage C (III) disease. Some aspects of colorectal cancer remain controversial, particularly screening recommendations and monitoring of carcinoembryonic antigen levels.
authors.affiliation: University of Kansas School of Medicine, Wichita.
authors.forename: M W
authors.initials: MW
authors.lastname: Lee
mesh_terms: D002272:Carcinoembryonic Antigen / Q000032:analysis; D017024:Chemotherapy, Adjuvant; D003110:Colonic Neoplasms / Q000235:genetics; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D007978:Levamisole / Q000627:therapeutic use; D008403:Mass Screening; D008991:Monitoring, Physiologic; D012004:Rectal Neoplasms / Q000235:genetics; D012307:Risk Factors
chemical_list: D002272:Carcinoembryonic Antigen; D007978:Levamisole; D005472:Fluorouracil